{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:00:50Z","timestamp":1766048450552},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2013.12.040","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T05:00:47Z","timestamp":1389070847000},"page":"767-779","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review"],"prefix":"10.1016","volume":"132","author":[{"given":"Anne F.","family":"Rositch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Soeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabatha N.","family":"Offutt-Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford S.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.12.040_bb0005","first-page":"1382","article-title":"Progress toward implementation of human papillomavirus vaccination\u2014the Americas, 2006\u20132010","volume":"60","author":"Centers for Disease C, Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0010","article-title":"Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]","volume":"v12","author":"Ferlay","year":"2010"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0950-3552(05)80357-8","article-title":"Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus","volume":"9","author":"Cox","year":"1995","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0025","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ijc.21604","article-title":"Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia","volume":"118","author":"Soutter","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/gyno.2000.5952","article-title":"Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?","volume":"79","author":"Nagai","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0035","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1054\/bjoc.2000.1689","article-title":"Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia","volume":"84","author":"Nobbenhuis","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/gyno.1997.4753","article-title":"Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri","volume":"66","author":"Chua","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s10096-006-0172-5","article-title":"Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies","volume":"25","author":"Tachezy","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/gyno.1998.5250","article-title":"Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology","volume":"72","author":"Bollen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0060","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1471-0528.2006.01063.x","article-title":"Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation","volume":"113","author":"Verguts","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0065","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","article-title":"Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study","volume":"12","author":"Kocken","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ijc.23824","article-title":"Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual\/recurrent disease","volume":"124","author":"Bais","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0080","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1086\/598981","article-title":"Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections","volume":"199","author":"Castle","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1741-7015-8-40","article-title":"Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa","volume":"8","author":"Taylor","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0090","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ijc.25745","article-title":"Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation","volume":"129","author":"Heymans","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/014107689008300804","article-title":"Effect of perilesional injection of alpha-interferon on cervical intraepithelial neoplasia and associated human papillomavirus infection","volume":"83","author":"Dunham","year":"1990","journal-title":"J R Soc Med"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0100","first-page":"453","article-title":"Human papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil","volume":"37","author":"Brodman","year":"1992","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0029-7844(02)02280-9","article-title":"Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia","volume":"100","author":"Elfgren","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jmv.20800","article-title":"High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: significance of newly detected hr-HPV genotypes","volume":"79","author":"van Ham","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0115","first-page":"589","article-title":"Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade III \u2014 a prospective study","volume":"13","author":"Nagai","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2004.05.012","article-title":"Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ)","volume":"31","author":"Sarian","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0125","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ygyno.2005.10.028","article-title":"Persistent HPV infection after conization in patients with negative margins","volume":"101","author":"Song","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2007.12.032","article-title":"PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia","volume":"109","author":"Fambrini","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2303.2008.00567.x","article-title":"Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia","volume":"20","author":"Aerssens","year":"2009","journal-title":"Cytopathology"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3802\/jgo.2009.20.2.91","article-title":"Factors associated with HPV persistence after conization in patients with negative margins","volume":"20","author":"Nam","year":"2009","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ijc.10691","article-title":"The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia","volume":"102","author":"Bekkers","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00404-009-1298-3","article-title":"Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions","volume":"282","author":"Baloglu","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0155","first-page":"441","article-title":"Efficacy of CO2 laser surgery in treating squamous intraepithelial lesions. An analysis of clinical and virologic results","volume":"39","author":"Sesti","year":"1994","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1098-0997(1998)6:5<214::AID-IDOG5>3.0.CO;2-I","article-title":"Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision","volume":"6","author":"Distefano","year":"1998","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0165","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1067\/mob.2000.107322","article-title":"Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser","volume":"183","author":"Kjellberg","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jnci\/djp089","article-title":"Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study","volume":"101","author":"Melnikow","year":"2009","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.26349","article-title":"Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment","volume":"131","author":"Kreimer","year":"2012","journal-title":"Int J Cancer"},{"issue":"72","key":"10.1016\/j.ygyno.2013.12.040_bb0180","first-page":"e1","article-title":"Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure","volume":"203","author":"Kang","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jcv.2011.06.021","article-title":"Human Papillomavirus genotype testing combined with cytology as a \u2018test of cure\u2019 post treatment: the importance of a persistent viral infection","volume":"52","author":"Jones","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00404-009-1316-5","article-title":"Role of HPV testing in the follow-up of women treated for cervical dysplasia","volume":"282","author":"Ribaldone","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0195","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0200","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/cid\/cir1036","article-title":"Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study","volume":"54","author":"Swedish","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?","volume":"130","author":"Kang","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0210","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-12-2635","article-title":"Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women","volume":"72","author":"Rositch","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0215","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/428779","article-title":"A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica","volume":"191","author":"Castle","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0220","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer","volume":"180","author":"Franco","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0225","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0230","doi-asserted-by":"crossref","first-page":"e7086","DOI":"10.1136\/bmj.e7086","article-title":"Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study","volume":"345","author":"Legood","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.ygyno.2013.12.040_bb0240","first-page":"e1","article-title":"Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping","volume":"201","author":"Brismar","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0245","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9378(96)70330-7","article-title":"Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens","volume":"174","author":"Elfgren","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0250","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/jmv.21198","article-title":"Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment","volume":"80","author":"Venturoli","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1479-828X.2010.01280.x","article-title":"Prediction of residual\/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins","volume":"51","author":"Wu","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.12.040_bb0260","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/sj.bjc.6601204","article-title":"Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections","volume":"89","author":"Bekkers","year":"2003","journal-title":"Br J Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T18:56:58Z","timestamp":1565031418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090825814000031"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.040","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}